EGFR and non-small cell lung carcinoma: Patients with NSCLC harboring ucm-EGFRm had a poorer response, lower ORR, and shorter PFS than patients with 19del/L858R after receiving EGFR-TKIs (Wu et al., 2011; Watanabe et al., 2014; Yang et al., 2015; Yang et al., 2020).